BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 15, 2013
View Archived Issues
Research uncovers benefit of combined PI3K/mTOR and JAK2 inhibition
Read More
PET imaging agent predicts response to liposomal chemotherapeutics
Read More
New GPR119 receptor agonists presented by Taisho Pharmaceutical
Read More
Regeneron Pharmaceuticals patents novel antibodies to hANGPTL3
Read More
Novel catechol derivatives presented by Edison Pharmaceuticals
Read More
Eli Lilly presents novel aldosterone synthase inhibitors
Read More
GlobeImmune patents new hepatitis D vaccines
Read More
New endothelial lipase inhibitors synthesized at Shionogi & Co.
Read More
p25/Cdk5 targeting shows promise in animal models of neurodegenerative disease
Read More
Novartis Pharma launches Tobi for respiratory infection in cystic fibrosis in Japan
Read More
SanBio enrolls second patient cohort in SB-623 stem cell trial
Read More
GlaxoSmithKline submits albiglutide BLA
Read More
Quillivant XR oral suspension launched in the U.S.
Read More
Epadel completes phase II study in NASH
Read More
BioTime submits protocol to initiate human trials of Renevia in Europe
Read More
Patrys progresses phase I/IIa PAT-SM6 trial to second patient group
Read More
Neuralstem cleared to conduct phase I trial of stem cell product in spinal cord injury
Read More
Uluru launches Altrazeal blister pack in the U.S.
Read More
Reviva completes enrollment in phase II trial of RP-5063
Read More
VG Life Sciences expands phase I ovarian cancer trial into all solid tumors
Read More
FDA approves Uceris for induction of remission in ulcerative colitis
Read More
Sanofi launches Amaryl OD 0.5 mg in Japan
Read More
Bayer Healthcare patents novel Mnk1 inhibitors for cancer
Read More
